Breaking News Instant updates and real-time market news.

PRTG

Portage Biotech

$5.75 /

-0.15 (-2.54%)

06:09
12/01/22
12/01
06:09
12/01/22
06:09

Portage Biotech price target lowered to $21 from $22 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns lowered the firm's price target on Portage Biotech to $21 from $22 and keeps a Buy rating on the shares post the Q2 results.

OTHER BREAKING NEWS FROM THE FLY

Technical Analysis
Market Vectors Semiconductor: Pivot points » 08:24
03/29/23
03/29
08:24
03/29/23
08:24
SMH

Market Vectors Semiconductor

$249.82 /

-1.65 (-0.66%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMH Market Vectors Semiconductor
$249.82 /

-1.65 (-0.66%)

SMH Market Vectors Semiconductor
$249.82 /

-1.65 (-0.66%)

SMH Market Vectors Semiconductor
$249.82 /

-1.65 (-0.66%)

SMH Market Vectors Semiconductor
$249.82 /

-1.65 (-0.66%)

Technical Analysis
Invesco QQQ Trust: Pivot points » 08:24
03/29/23
03/29
08:24
03/29/23
08:24
QQQ

Invesco QQQ Trust

$307.10 /

-1.605 (-0.52%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QQQ Invesco QQQ Trust
$307.10 /

-1.605 (-0.52%)

QQQ Invesco QQQ Trust
$307.10 /

-1.605 (-0.52%)

04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
QQQ Invesco QQQ Trust
$307.10 /

-1.605 (-0.52%)

QQQ Invesco QQQ Trust
$307.10 /

-1.605 (-0.52%)

QQQ Invesco QQQ Trust
$307.10 /

-1.605 (-0.52%)

Recommendations
Viking Therapeutics price target raised to $19 from $15 at Roth MKM » 08:23
03/29/23
03/29
08:23
03/29/23
08:23
VKTX

Viking Therapeutics

$15.41 /

+6.28 (+68.78%)

Roth MKM raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

08:12 Today Maxim
Viking Therapeutics price target raised to $25 from $15 at Maxim
06:15 Today Raymond James
Viking Therapeutics price target raised to $35 from $12 at Raymond James
03/28/23 BTIG
Viking Therapeutics price target raised to $31 from $20 at BTIG
03/28/23 Oppenheimer
Viking Therapeutics price target raised to $30 from $20 at Oppenheimer
VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

Earnings
Twin Vee PowerCats reports 2022 EPS (76c) vs. (19c) last year » 08:22
03/29/23
03/29
08:22
03/29/23
08:22
VEEE

Twin Vee PowerCats

$1.84 /

+0.13 (+7.60%)

Reports revenue $32M vs.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VEEE Twin Vee PowerCats
$1.84 /

+0.13 (+7.60%)

VEEE Twin Vee PowerCats
$1.84 /

+0.13 (+7.60%)

  • 29
    Sep
Recommendations
Other EV startups may need to consider actions like Lucid, says Morgan Stanley » 08:22
03/29/23
03/29
08:22
03/29/23
08:22
LCID

Lucid Group

$7.56 /

-0.58 (-7.13%)

, RIVN

Rivian Automotive

$12.98 /

-0.345 (-2.59%)

, LI

Li Auto

$24.77 /

+1.58 (+6.81%)

, NIO

Nio

$9.21 /

+0.27 (+3.02%)

, XPEV

XPeng

$10.25 /

+0.55 (+5.67%)

After Lucid Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LCID Lucid Group
$7.56 /

-0.58 (-7.13%)

RIVN Rivian Automotive
$12.98 /

-0.345 (-2.59%)

LI Li Auto
$24.77 /

+1.58 (+6.81%)

NIO Nio
$9.21 /

+0.27 (+3.02%)

XPEV XPeng
$10.25 /

+0.55 (+5.67%)

LCID Lucid Group
$7.56 /

-0.58 (-7.13%)

03/02/23 Citi
Lucid Group price target lowered to $11.50 from $12 at Citi
02/23/23 R.F. Lafferty
Lucid Group price target lowered to $12 from $17 at R.F. Lafferty
02/23/23 Exane BNP Paribas
Lucid Group downgraded to Neutral from Outperform at Exane BNP Paribas
02/23/23 Cantor Fitzgerald
Lucid Group price target lowered to $13 from $18 at Cantor Fitzgerald
RIVN Rivian Automotive
$12.98 /

-0.345 (-2.59%)

03/22/23 Morgan Stanley
Rivian now trading just below cash value, says Morgan Stanley
03/21/23 Morgan Stanley
EV price cuts 'not a fad, but a trend,' says Morgan Stanley
03/10/23 BofA
Rivian Automotive resumed with Buy, reduced target at BofA
03/09/23 Mizuho
Rivian Automotive price target lowered to $35 from $37 at Mizuho
LI Li Auto
$24.77 /

+1.58 (+6.81%)

03/20/23 Morgan Stanley
XPeng price target raised to $12.50 from $12 at Morgan Stanley
03/20/23 Morgan Stanley
Li Auto price target raised to $30 from $23 at Morgan Stanley
03/20/23 Morgan Stanley
Nio price target lowered to $12 from $16.10 at Morgan Stanley
03/03/23 HSBC
Li Auto price target raised to $36 from $35 at HSBC
NIO Nio
$9.21 /

+0.27 (+3.02%)

03/20/23 Morgan Stanley
XPeng price target raised to $12.50 from $12 at Morgan Stanley
03/20/23 Morgan Stanley
Li Auto price target raised to $30 from $23 at Morgan Stanley
03/20/23 Morgan Stanley
Nio price target lowered to $12 from $16.10 at Morgan Stanley
03/02/23 Mizuho
Nio price target lowered to $25 from $28 at Mizuho
XPEV XPeng
$10.25 /

+0.55 (+5.67%)

03/24/23 Bernstein
XPeng downgraded to Market Perform from Outperform at Bernstein
03/24/23 Bernstein
XPeng downgraded to Market Perform from Outperform at Bernstein
03/20/23 Morgan Stanley
XPeng price target raised to $12.50 from $12 at Morgan Stanley
03/20/23 Morgan Stanley
Li Auto price target raised to $30 from $23 at Morgan Stanley
LCID Lucid Group
$7.56 /

-0.58 (-7.13%)

RIVN Rivian Automotive
$12.98 /

-0.345 (-2.59%)

LI Li Auto
$24.77 /

+1.58 (+6.81%)

NIO Nio
$9.21 /

+0.27 (+3.02%)

XPEV XPeng
$10.25 /

+0.55 (+5.67%)

LCID Lucid Group
$7.56 /

-0.58 (-7.13%)

RIVN Rivian Automotive
$12.98 /

-0.345 (-2.59%)

LI Li Auto
$24.77 /

+1.58 (+6.81%)

NIO Nio
$9.21 /

+0.27 (+3.02%)

XPEV XPeng
$10.25 /

+0.55 (+5.67%)

LCID Lucid Group
$7.56 /

-0.58 (-7.13%)

RIVN Rivian Automotive
$12.98 /

-0.345 (-2.59%)

LI Li Auto
$24.77 /

+1.58 (+6.81%)

NIO Nio
$9.21 /

+0.27 (+3.02%)

XPEV XPeng
$10.25 /

+0.55 (+5.67%)

LCID Lucid Group
$7.56 /

-0.58 (-7.13%)

RIVN Rivian Automotive
$12.98 /

-0.345 (-2.59%)

LI Li Auto
$24.77 /

+1.58 (+6.81%)

NIO Nio
$9.21 /

+0.27 (+3.02%)

XPEV XPeng
$10.25 /

+0.55 (+5.67%)

Recommendations
Lovesac price target raised to $36 from $32 at Roth MKM » 08:21
03/29/23
03/29
08:21
03/29/23
08:21
LOVE

Lovesac

$27.01 /

+3.055 (+12.75%)

Roth MKM analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOVE Lovesac
$27.01 /

+3.055 (+12.75%)

LOVE Lovesac
$27.01 /

+3.055 (+12.75%)

12/08/22 DA Davidson
Lovesac price target lowered to $64 from $97 at DA Davidson
12/08/22 Craig-Hallum
Lovesac price target lowered to $60 from $100 at Craig-Hallum
12/08/22 Canaccord
Lovesac price target lowered to $50 from $55 at Canaccord
09/09/22 DA Davidson
Lovesac price target lowered to $97 from $124 at DA Davidson
LOVE Lovesac
$27.01 /

+3.055 (+12.75%)

LOVE Lovesac
$27.01 /

+3.055 (+12.75%)

LOVE Lovesac
$27.01 /

+3.055 (+12.75%)

Hot Stocks
Achieve Life says last subject's last visit complete for Phase 3 ORCA-3 trial » 08:20
03/29/23
03/29
08:20
03/29/23
08:20
ACHV

Achieve Life Sciences

$5.55 /

+0.425 (+8.29%)

Achieve Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHV Achieve Life Sciences
$5.55 /

+0.425 (+8.29%)

ACHV Achieve Life Sciences
$5.55 /

+0.425 (+8.29%)

11/16/22 Maxim
Achieve Life Sciences price target lowered to $8 from $21 at Maxim
11/15/22 Oppenheimer
Achieve Life Sciences price target lowered to $20 from $27 at Oppenheimer
04/27/22 Oppenheimer
Achieve Life Sciences price target raised to $27 from $23 at Oppenheimer
ACHV Achieve Life Sciences
$5.55 /

+0.425 (+8.29%)

ACHV Achieve Life Sciences
$5.55 /

+0.425 (+8.29%)

Hot Stocks
Proterra announces South Carolina Department of Education to deploy 160 TBB » 08:20
03/29/23
03/29
08:20
03/29/23
08:20
PTRA

Proterra

$1.50 /

+0.05 (+3.45%)

The South Carolina…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTRA Proterra
$1.50 /

+0.05 (+3.45%)

PTRA Proterra
$1.50 /

+0.05 (+3.45%)

03/17/23 DA Davidson
Proterra price target lowered to $5 from $10 at DA Davidson
03/16/23 BTIG
Proterra price target lowered to $6 from $7 at BTIG
10/17/22 BTIG
Proterra initiated with a Buy at BTIG
09/28/22 Truist
Truist starts Proterra at Buy, positive on commercial EV battery niche
PTRA Proterra
$1.50 /

+0.05 (+3.45%)

PTRA Proterra
$1.50 /

+0.05 (+3.45%)

PTRA Proterra
$1.50 /

+0.05 (+3.45%)

Hot Stocks
BioCardia sees cash runway into 3Q23 » 08:19
03/29/23
03/29
08:19
03/29/23
08:19
BCDA

BioCardia

$2.19 /

+0.1 (+4.78%)

Net cash used in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

11/17/22 Alliance Global Partners
BioCardia price target lowered to $6 from $11.50 at Alliance Global Partners
11/11/22 Dawson James
BioCardia downgraded to Neutral from Buy at Dawson James
BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

Earnings
BioCardia reports 2022 EPS (67c) vs. (75c) last year » 08:19
03/29/23
03/29
08:19
03/29/23
08:19
BCDA

BioCardia

$2.19 /

+0.1 (+4.78%)

Reports 2022 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

11/17/22 Alliance Global Partners
BioCardia price target lowered to $6 from $11.50 at Alliance Global Partners
11/11/22 Dawson James
BioCardia downgraded to Neutral from Buy at Dawson James
BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

BCDA BioCardia
$2.19 /

+0.1 (+4.78%)

Hot Stocks
Olink technology enables further development of South African research » 08:18
03/29/23
03/29
08:18
03/29/23
08:18
OLK

Olink

$19.83 /

-1.8 (-8.32%)

Olink announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLK Olink
$19.83 /

-1.8 (-8.32%)

OLK Olink
$19.83 /

-1.8 (-8.32%)

01/05/23 Scotiabank
Olink initiated with an Outperform at Scotiabank
01/04/23 Scotiabank
Olink initiated with an Outperform at Scotiabank
12/14/22 Canaccord
Olink initiated with a Buy at Canaccord
OLK Olink
$19.83 /

-1.8 (-8.32%)

  • 19
    Jan
OLK Olink
$19.83 /

-1.8 (-8.32%)

Hot Stocks
Verses, SimWell partner to enhance digital twin stimulations with KOSMOS » 08:17
03/29/23
03/29
08:17
03/29/23
08:17
VRSSF

Verses Technologies

/

+

VERSES Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSSF Verses Technologies
/

+

Hot Stocks
Crispr Therapeutics announces departure of board member » 08:16
03/29/23
03/29
08:16
03/29/23
08:16
CRSP

Crispr Therapeutics

$43.84 /

-0.49 (-1.11%)

CRISPR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

03/21/23 Bernstein
Crispr Therapeutics initiated with a Market Perform at Bernstein
03/18/23 Citi
Crispr Therapeutics price target lowered to $55 from $63 at Citi
03/17/23 Bryan Garnier
Crispr Therapeutics initiated with a Buy at Bryan Garnier
03/06/23 Baird
Baird starts Crispr at Neutral with strong launch priced in
CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

CRSP Crispr Therapeutics
$43.84 /

-0.49 (-1.11%)

Hot Stocks
G Medical Innovations enters into agreement with AdventHealth Central Florida » 08:15
03/29/23
03/29
08:15
03/29/23
08:15
GMVD

G Medical Innovations

$1.89 /

-0.05 (-2.58%)

G Medical Innovations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMVD G Medical Innovations
$1.89 /

-0.05 (-2.58%)

Hot Stocks
Caribou initiates dose expansion portion of CB-010 ANTLER Phase 1 trial » 08:15
03/29/23
03/29
08:15
03/29/23
08:15
CRBU

Caribou Biosciences

$4.71 /

+0.02 (+0.43%)

Caribou Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

03/18/23 BofA
Caribou Biosciences price target lowered to $25 from $27 at BofA
03/14/23 H.C. Wainwright
Caribou Biosciences price target lowered to $26 from $27 at H.C. Wainwright
03/10/23 Oppenheimer
Caribou Biosciences price target lowered to $32 from $36 at Oppenheimer
11/23/22 Citi
Caribou Biosciences price target lowered to $37 from $38 at Citi
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

Hot Stocks
First Solar announces facility in India awarded financial incentives » 08:13
03/29/23
03/29
08:13
03/29/23
08:13
FSLR

First Solar

$210.01 /

+0.08 (+0.04%)

First Solar announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

03/23/23 Barclays
First Solar price target raised to $230 from $162 at Barclays
03/15/23 Credit Suisse
First Solar price target raised to $163 from $152 at Credit Suisse
03/14/23 Argus
First Solar price target raised to $261 from $176 at Argus
03/09/23 Citi
First Solar transferred with Neutral rating at Citi
FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

FSLR First Solar
$210.01 /

+0.08 (+0.04%)

Hot Stocks
Caribou Biosciences doses first patient in CaMMouflage Phase 1 trial of CB-011 » 08:12
03/29/23
03/29
08:12
03/29/23
08:12
CRBU

Caribou Biosciences

$4.71 /

+0.02 (+0.43%)

Caribou Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

03/18/23 BofA
Caribou Biosciences price target lowered to $25 from $27 at BofA
03/14/23 H.C. Wainwright
Caribou Biosciences price target lowered to $26 from $27 at H.C. Wainwright
03/10/23 Oppenheimer
Caribou Biosciences price target lowered to $32 from $36 at Oppenheimer
11/23/22 Citi
Caribou Biosciences price target lowered to $37 from $38 at Citi
CRBU Caribou Biosciences
$4.71 /

+0.02 (+0.43%)

Recommendations
Viking Therapeutics price target raised to $25 from $15 at Maxim » 08:12
03/29/23
03/29
08:12
03/29/23
08:12
VKTX

Viking Therapeutics

$15.41 /

+6.28 (+68.78%)

Maxim raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

06:15 Today Raymond James
Viking Therapeutics price target raised to $35 from $12 at Raymond James
03/28/23 BTIG
Viking Therapeutics price target raised to $31 from $20 at BTIG
03/28/23 Oppenheimer
Viking Therapeutics price target raised to $30 from $20 at Oppenheimer
03/28/23 Stifel
Stifel reiterates Buy on Viking Therapeutics, raises price target to $25
VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

VKTX Viking Therapeutics
$15.41 /

+6.28 (+68.78%)

Hot Stocks
Enphase Energy launches new IQ8 microinverters in France, the Netherlands » 08:12
03/29/23
03/29
08:12
03/29/23
08:12
ENPH

Enphase Energy

$193.50 /

-2.28 (-1.16%)

Enphase Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

03/22/23 Susquehanna
Enphase upgraded to Positive on recent pullback at Susquehanna
03/22/23 Susquehanna
Enphase Energy upgraded to Positive from Neutral at Susquehanna
03/20/23 Raymond James
Enphase Energy upgraded to Outperform from Market Perform at Raymond James
03/09/23 Citi
Enphase Energy transferred with Buy rating at Citi
ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

ENPH Enphase Energy
$193.50 /

-2.28 (-1.16%)

Hot Stocks
Akari announces Poland, U.K. approve new manufacturing process for nomacopan » 08:10
03/29/23
03/29
08:10
03/29/23
08:10
AKTX

Akari Therapeutics

/

+

Akari Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
/

+

AKTX Akari Therapeutics
/

+

12/05/22 H.C. Wainwright
Akari Therapeutics initiated with a Buy at H.C. Wainwright
11/01/22 Alliance Global Partners
Akari Therapeutics initiated with a Buy at Alliance Global Partners
Upgrade
Anhui Conch Cement upgraded to Neutral from Sell at Goldman Sachs » 08:10
03/29/23
03/29
08:10
03/29/23
08:10
AHCHY

Anhui Conch Cement

$17.45 /

+0.26 (+1.51%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHCHY Anhui Conch Cement
$17.45 /

+0.26 (+1.51%)

11/15/22 HSBC
Anhui Conch Cement upgraded to Buy from Hold at HSBC
08/28/22 Goldman Sachs
Anhui Conch Cement downgraded to Sell from Neutral at Goldman Sachs
Hot Stocks
Kala Pharmaceuticals appoints Francis Mah as chief medical advisor » 08:10
03/29/23
03/29
08:10
03/29/23
08:10
KALA

Kala Pharmaceuticals

$15.59 /

+0.59 (+3.93%)

Kala Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

03/06/23 H.C. Wainwright
Kala Pharmaceuticals price target raised to $20 from $12 at H.C. Wainwright
12/29/22 Wedbush
IND acceptance sets up Kala for execution year in 2023, says Wedbush
11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

KALA Kala Pharmaceuticals
$15.59 /

+0.59 (+3.93%)

Hot Stocks
NV5 awarded $11M essential infrastructure projects in California, New Mexico » 08:09
03/29/23
03/29
08:09
03/29/23
08:09
NVEE

NV5 Global

$100.90 /

+0.02 (+0.02%)

NV5 Global announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$100.90 /

+0.02 (+0.02%)

NVEE NV5 Global
$100.90 /

+0.02 (+0.02%)

02/24/23 Baird
NV5 Global price target lowered to $130 from $150 at Baird
08/05/22 Lake Street
NV5 Global price target raised to $175 from $136 at Lake Street
NVEE NV5 Global
$100.90 /

+0.02 (+0.02%)

Hot Stocks
DoubleDown announces results of 2023 Annual General Meeting » 08:09
03/29/23
03/29
08:09
03/29/23
08:09
DDI

DoubleDown

$8.09 /

+0.08 (+1.00%)

DoubleDown Interactive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDI DoubleDown
$8.09 /

+0.08 (+1.00%)

DDI DoubleDown
$8.09 /

+0.08 (+1.00%)

09/15/22 Macquarie
DoubleDown initiated with an Outperform at Macquarie
07/11/22 B. Riley
Investors have overlooked DoubleDown, says B. Riley
06/28/22 B. Riley
DoubleDown price target lowered to $20 from $30 at B. Riley
Initiation
Engie Brasil initiated with an Outperform at Scotiabank » 08:09
03/29/23
03/29
08:09
03/29/23
08:09
EGIEY

Engie Brasil

$8.00 /

+0.34 (+4.44%)

Scotiabank analyst Renato…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGIEY Engie Brasil
$8.00 /

+0.34 (+4.44%)

03/07/23 UBS
Engie Brasil upgraded to Buy from Neutral at UBS
01/10/23 JPMorgan
Engie Brasil upgraded to Overweight from Neutral at JPMorgan
10/14/22 JPMorgan
Engie Brasil upgraded to Neutral from Underweight at JPMorgan
08/08/22 JPMorgan
Engie Brasil downgraded to Underweight from Neutral at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.